Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055457/0963 | |
| Pages: | 10 |
| | Recorded: | 03/02/2021 | | |
| Attorney Dkt #: | 034186-095790USPT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16913735
|
Filing Dt:
|
06/26/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
|
Title:
|
USE OF RIBONUCLEOTIDE REDUCTASE ALONE OR IN COMBINATION WITH MICRO-DYSTROPHIN TO TREAT DUCHENNE MUSCULAR DYSTROPHY STRIATED MUSCLE DISEASE
|
|
|
Assignee
|
|
|
|
|
| 4545 ROOSEVELT WAY NE |
| SUITE 400 |
| SEATTLE, WASHINGTON 98105 |
|
|
Correspondence name and address
|
| |
MARK J. FITZGERALD
|
| |
NIXON PEABODY LLP
|
| |
53 STATE STREET
|
| |
BOSTON, MA 02109-2835
|
Search Results as of:
04/27/2024 04:58 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
